Американский опыт лечения ЖДА в/в феринджектом - оценка некоторых показателей шкал здоровья до и спустя 3 мес. лечения (гемоглобин повысился с 102 до 128 г/л)
total of 152 patients were enrolled.
Mean age was 47.4 ± 16.0 years and 82.2% were female.
All patients were treated with at least one FCM dose at baseline, with 77.6% receiving a two-dose treatment course.
A minimum 5-point improvement, pre-defined as clinically meaningful, was seen in the
FACIT-Fatigue for 73%,
PROMIS Global Physical Health = 53%,
Global Mental Health = 42%,
PROMIS Physical Function scores = 40% of patients at 3 months...
---
Int J Gen Med.. 2023 Aug 2;16:3291-3300.
Patient-Reported Outcomes After Ferric Carboxymaltose Treatment for Iron Deficiency Anemia: A Prospective Observational Study
|